Literature DB >> 12020616

Nitric oxide in hepatic encephalopathy and hyperammonemia.

Vemuganti L Raghavendra Rao1.   

Abstract

Chronic alcoholism, viral hepatitis or hepatotoxic drug overdose result in liver dysfunction which may lead to a neuropsychiatric disorder termed hepatic encephalopathy (HE). Although, the exact molecular mechanisms underlying the pathophysiology of HE are not known, excitatory/inhibitory neurotransmitter imbalance leading to dysfunction of the glutamate-nitric oxide (NO) system is thought to play a major role. Activation of the NMDA subtype of glutamate receptors leads to increase in intracellular calcium, which initiates several calcium-dependent processes including NO formation. NO is a gaseous, highly reactive, freely diffusible molecule with a short half-life. Recent studies demonstrate increased expression of the neuronal isoform of NO synthase (NOS) and the uptake of L-arginine (the obligate precursor of NO) in both chronic and acute HE. Hyperammonemia associated with liver dysfunction results in increased NO, which may lead to learning and memory impairments and cerebral edema commonly seen, particularly in acute hyperammonemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020616     DOI: 10.1016/s0197-0186(02)00038-4

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  12 in total

Review 1.  Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  Neurochem Int       Date:  2011-10-01       Impact factor: 3.921

2.  Activation of neuronal nitric oxide synthase in cerebellum of chronic hepatic encephalopathy rats is associated with up-regulation of NADPH-producing pathway.

Authors:  Santosh Singh; Surendra K Trigun
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

Review 3.  Evidence for oxidative/nitrosative stress in the pathogenesis of hepatic encephalopathy.

Authors:  Chantal Bemeur; Paul Desjardins; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2010-03-02       Impact factor: 3.584

4.  Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.

Authors:  Josef Finsterer; Elisabeth Bernauer
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

Review 5.  Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide.

Authors:  Faqi Li; Zhao Zhong Chong; Kenneth Maiese
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 6.  Ammonia toxicity to the brain.

Authors:  Olivier Braissant; Valérie A McLin; Cristina Cudalbu
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

7.  Nitric oxide production in striatum and pallidum of cirrhotic rats.

Authors:  Sergio Montes; Francisca Pérez-Severiano; Paula Vergara; José Segovia; Camilo Ríos; Pablo Muriel
Journal:  Neurochem Res       Date:  2006-01       Impact factor: 3.996

8.  Citrulline uptake in rat cerebral cortex slices: modulation by Thioacetamide -Induced hepatic failure.

Authors:  Magdalena Zielińska; Marta Obara-Michlewska; Wojciech Hilgier; Jan Albrecht
Journal:  Metab Brain Dis       Date:  2014-01-03       Impact factor: 3.584

9.  Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology.

Authors:  Xia Cao; Zelan Wei; Geraldine G Gabriel; XinMin Li; Darrell D Mousseau
Journal:  BMC Neurosci       Date:  2007-09-16       Impact factor: 3.288

10.  The protective role of Bax inhibitor-1 against chronic mild stress through the inhibition of monoamine oxidase A.

Authors:  Hwa-Young Lee; Geum-Hwa Lee; Anu Marahatta; Shun-Mei Lin; Mi-Rin Lee; Kyu Yun Jang; Kyung Min Kim; Hee Jae Lee; Jae-Won Lee; Tarique Rajasaheb Bagalkot; Young-Chul Chung; Yong-Chul Lee; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Sci Rep       Date:  2013-12-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.